The Effect of Flossing to Joint Range of Motion.

March 1, 2023 updated by: Malá Jitka, Charles University, Czech Republic

Influence of Flossing Tape Therapy on the Range of Motion and Influencing of Fascial Chains in the Lower Limbs

This research aims to verify the effect of therapy called "tissue flossing" on the range of motion and examine the impact of this treatment on the Superficial fascial backline, described by Myers. The research aims to verify whether the thick rubber bands used to create a certain degree of compression in a predetermined part of the musculoskeletal system can help to increase the range of motion (ROM) and whether this increase in motion can be achieved by influencing fascial chains even in distant parts of the musculoskeletal system, outside the primary therapeutic zone treated by the tissue flossing method. The research aims to verify and especially compare the patient's joints' range of motion before and immediately after the tissue flossing treatment. The results of the experiment clarify the influence of the tissue flossing therapy method on the range of motion at the application site, on the range of motion in other joints within the Superficial fascial backline described by Myers and last but not least to prove the existence of these fascial chains in the human body.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Methodology:

The weight-bearing lunge test (WBLT) was used to evaluate the change in the ankle joint's range of motion. A simple forward bend test - the Thomayer test - was used to evaluate the therapy's effect on the Superficial fascial backline described by Myers. Both tests are non-invasive. Both tests can be used to evaluate the outcome of a given therapy objectively. Both tests are elementary to perform and highly standardized and commonly used in similar research.

After completing the entrance tests, the tissue flossing method is applied to each proband. The treatment alone does not typically last more than 20 minutes for any proband. As part of the tissue flossing treatment, both lower limbs of the proband will be treated. The "tissue flossing" method will be applied according to the authors' standard recommendations first to the plantar fascia area, then to the ankle joint. Finally, the last treated structure will be the area of fascia cruris. The duration of each application does not exceed 2 minutes. The order of individual applications is determined in advance as follows: right and then left plantar fascia, right and then left ankle joint and right and then left fascia cruris. Each application will be supplemented by the standard manual treatment or supplemented by the proband's active movement. After a total of 6 treatments, the therapeutic unit will be finished, and each proband will be re-examined using the same tests as before the treatment. If a given proband experiences any undesirable complications during the application of the "tissue flossing" method or applying the given method to the proband is subjectively unpleasant, the given treatment will be finished immediately.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Praha, Czechia
        • Charles University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 26 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • No previous experience with the tissue flossing method
  • Each proband had to do recreational or elite sports

Exclusion Criteria:

  • persons with an acute, especially infectious disease, person with an injury or persons in the process of recovery after an injury or illness
  • vascular diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
Testing of the ankle in sagittal line and Thomayer test before and after flossing of sole.
Other Names:
  • Dorziflexion of an ankle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of range of motion of ankle in sagital line
Time Frame: 5 minutes
Measurement without flossing of sole in natura
5 minutes
Measurement of range of motion of ankle in sagital line
Time Frame: 15 minutes
Flossing of sole and than measurement after flossing of sole
15 minutes
Measurement of range of motion of lumbar spine in sagital line
Time Frame: 5 minutes
Measurement before flossing of sole
5 minutes
Measurement of range of motion of lumbar spine in sagital line
Time Frame: 15 minutes
Measurement after flossing of sole
15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jitka Malá, PhDr.Ph.D., Charles University, Faculty of physical education and sport

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Actual)

March 30, 2021

Study Completion (Actual)

April 30, 2021

Study Registration Dates

First Submitted

December 23, 2020

First Submitted That Met QC Criteria

December 26, 2020

First Posted (Actual)

December 30, 2020

Study Record Updates

Last Update Posted (Actual)

March 2, 2023

Last Update Submitted That Met QC Criteria

March 1, 2023

Last Verified

December 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle, Ligament and Fascia Disorders

Clinical Trials on Thomayer test

3
Subscribe